Indicators of questionable research practices were identified in 163,129 randomized controlled trials

Johanna AAG Damen; Pauline Heus; Herm J. Lamberink; Joeri K. Tijdink; L.M. Bouter; Paul Glasziou; David Moher; Willem M. Otte; Christiaan H. Vinkers; Lotty Hooft

doi:10.1016/j.jclinepi.2022.11.020

Back

Indicators of questionable research practices were identified in 163,129 randomized controlled trials

Article 2022 en

Abstract

1 min read

This comprehensive analysis provides an insight into indicators of QRPs. Researchers should be aware that certain characteristics of the author team and publication are associated with a higher risk of QRPs.

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Preprint2025

Trustworthiness and Transparency Features Were Less Frequent in Randomized Trials Presenting Large Effects in Abstracts

Jonathan Henssler, Joana Reis‐Pardal, Lina Koppel, John P A Ioannidis

Article2014

The Future of Observational Research and Randomized Controlled Trials in Red Blood Cell Transfusion Medicine

Jean Louis Vincent, Yasser Sakr, Christophe Lelubre

Article2008

Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias

Kerry Dwan, Douglas G. Altman, Juan A. Arnaiz, Jill Bloom, An‐Wen Chan, Eugenia Cronin, Évelyne Decullier, Philippa Easterbrook, Erik von Elm, Carrol Gamble, Davina Ghersi, John P A Ioannidis, John Simes, Paula Williamson

Article2021

Bibliometrics of Latin American research on COVID-19 in the first year of the pandemic: the main trends

Wen-Ta Chiu, Yuh-shan Ho

Preprint2024

A Bibliometric Analysis of Highly Cited Artificial Intelligence Publications in Science Citation Index Expanded

Yuh-shan Ho, Juan José Prieto Gutiérrez